126 related articles for article (PubMed ID: 11920522)
1. Expression of tumor rejection antigens in colorectal carcinomas.
Sasatomi T; Suefuji Y; Matsunaga K; Yamana H; Miyagi Y; Araki Y; Ogata Y; Itoh K; Shirouzu K
Cancer; 2002 Mar; 94(6):1636-41. PubMed ID: 11920522
[TBL] [Abstract][Full Text] [Related]
2. Expression of tumor-rejection antigens in gynecologic cancers.
Tanaka S; Tsuda N; Kawano K; Sakamoto M; Nishida T; Hashimoto T; Shichijo S; Kamura T; Itoh K
Jpn J Cancer Res; 2000 Nov; 91(11):1177-84. PubMed ID: 11092984
[TBL] [Abstract][Full Text] [Related]
3. Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients.
Suefuji Y; Sasatomi T; Shichijo S; Nakagawa S; Deguchi H; Koga T; Kameyama T; Itoh K
Br J Cancer; 2001 Apr; 84(7):915-9. PubMed ID: 11286471
[TBL] [Abstract][Full Text] [Related]
4. Expression of the SART3 tumor rejection antigen in renal cell carcinoma.
Kawagoe N; Shintaku I; Yutani S; Etoh H; Matuoka K; Noda S; Itoh K
J Urol; 2000 Dec; 164(6):2090-5. PubMed ID: 11061933
[TBL] [Abstract][Full Text] [Related]
5. Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides.
Murayama K; Kobayashi T; Imaizumi T; Matsunaga K; Kuramoto T; Shigemori M; Shichijo S; Itoh K
J Immunother; 2000; 23(5):511-8. PubMed ID: 11001544
[TBL] [Abstract][Full Text] [Related]
6. Expression of SART3 tumor-rejection antigen in gastric cancers.
Niiya F; Nishizaka S; Matsunaga K; Koufuji K; Mori M; Katai H; Yamana H; Itoh K
Jpn J Cancer Res; 2000 Mar; 91(3):337-42. PubMed ID: 10760694
[TBL] [Abstract][Full Text] [Related]
7. Expression of the SART3 antigens in oral cancers.
Fukuda K
Kurume Med J; 2001; 48(1):55-8. PubMed ID: 11402621
[TBL] [Abstract][Full Text] [Related]
8. Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytes by SART3-derived peptides.
Tsuda N; Murayama K; Ishida H; Matsunaga K; Komiya S; Itoh K; Yamada A
J Orthop Res; 2001 May; 19(3):346-51. PubMed ID: 11398844
[TBL] [Abstract][Full Text] [Related]
9. Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas.
Yutani S; Shichijo S; Inoue Y; Kawagoe N; Okuda K; Kurohiji T; Tanaka M; Sata M; Itoh K
Oncol Rep; 2001; 8(2):369-72. PubMed ID: 11182058
[TBL] [Abstract][Full Text] [Related]
10. Expression of the SART1 tumor-rejection antigens in colorectal cancers.
Sasatomi T; Yamana H; Shichijo S; Tanaka S; Okamura T; Ogata Y; Itoh K; Shirouzu K
Dis Colon Rectum; 2000 Dec; 43(12):1754-8. PubMed ID: 11156463
[TBL] [Abstract][Full Text] [Related]
11. Expression of the SART1 tumor rejection antigen in renal cell carcinoma.
Shintaku I; Kawagoe N; Yutani S; Hoshi S; Orikasa S; Yoshizumi O; Itoh K
Urol Res; 2000 Jun; 28(3):178-84. PubMed ID: 10929426
[TBL] [Abstract][Full Text] [Related]
12. Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides.
Miyagi Y; Imai N; Sasatomi T; Yamada A; Mine T; Katagiri K; Nakagawa M; Muto A; Okouchi S; Isomoto H; Shirouzu K; Yamana H; Itoh K
Clin Cancer Res; 2001 Dec; 7(12):3950-62. PubMed ID: 11751487
[TBL] [Abstract][Full Text] [Related]
13. Expression of the SART1 tumor-rejection antigen in human osteosarcomas.
Ishida H; Komiya S; Inoue Y; Yutani S; Inoue A; Itoh K
Int J Oncol; 2000 Jul; 17(1):29-32. PubMed ID: 10853014
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinoma.
Komohara Y; Harada M; Arima Y; Suekane S; Noguchi M; Yamada A; Itoh K; Matsuoka K
Int J Oncol; 2006 Dec; 29(6):1555-60. PubMed ID: 17088996
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor Vbeta gene usage by T cells reactive with the tumor-rejection antigen SART-1 in oral squamous cell carcinoma.
Kumamaru W; Nakamura S; Kadena T; Yamada A; Kawamura E; Sasaki M; Ohyama Y; Toyoshima T; Hayashida JN; Itoh K; Shirasuna K
Int J Cancer; 2004 Feb; 108(5):686-95. PubMed ID: 14696095
[TBL] [Abstract][Full Text] [Related]
16. Expression of the tumor-rejection antigen SART1 in brain tumors.
Imaizumi T; Kuramoto T; Matsunaga K; Shichijo S; Yutani S; Shigemori M; Oizumi K; Itoh K
Int J Cancer; 1999 Dec; 83(6):760-4. PubMed ID: 10597192
[TBL] [Abstract][Full Text] [Related]
17. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes.
Shichijo S; Nakao M; Imai Y; Takasu H; Kawamoto M; Niiya F; Yang D; Toh Y; Yamana H; Itoh K
J Exp Med; 1998 Feb; 187(3):277-88. PubMed ID: 9449708
[TBL] [Abstract][Full Text] [Related]
18. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients.
Yang D; Nakao M; Shichijo S; Sasatomi T; Takasu H; Matsumoto H; Mori K; Hayashi A; Yamana H; Shirouzu K; Itoh K
Cancer Res; 1999 Aug; 59(16):4056-63. PubMed ID: 10463607
[TBL] [Abstract][Full Text] [Related]
19. Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.
Kaji K; Mizukoshi E; Yamashita T; Arai K; Sunagozaka H; Fushimi K; Nakagawa H; Yamada K; Terashima T; Kitahara M; Kaneko S
PLoS One; 2017; 12(1):e0170291. PubMed ID: 28114424
[TBL] [Abstract][Full Text] [Related]
20. Expression of the SART-1 antigens in uterine cancers.
Matsumoto H; Shichijo S; Kawano K; Nishida T; Sakamoto M; Itoh K
Jpn J Cancer Res; 1998 Dec; 89(12):1292-5. PubMed ID: 10081490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
